ArticleCell death discovery2024

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.

Wenqi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.